Form 4 for NEPH NEPHROS INC
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001437749-21-028834 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-16 | 2021-12-14 | NEPH | Spandow Oliver J. | Dir | A - Grant | $0.00 | +5,429 | 24.8K | +28% | $0 |
| D | 2021-12-16 | 2021-12-14 | NEPH | Spandow Oliver J. | Dir | A - Grant | $0.00 | +7,062 | 7,062 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-14 | A | A | 5,429 | $0.00 | 24,829 | D | — | — | (F1) Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-12-14 | A | A | 7,062 | $0.00 | 7,062 | D | $6.82 · — to 2031-12-14 | 7,062 Common Stock | (F4) Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23. |